Applying Decades of Experience with an Eye on the Future of Small Molecule Development For decades before antibody drugs were d...
Looking beyond the surface on the Complexity of Atopic Dermatitis Addressing inflammatory skin disorders like atopic dermatitis...
We took some time to sit down and talk with Jason so you could get to know him a bit better... My name is Jason Valentine. I'm...
We took some time to sit down and talk with Cameron so you could get to know him a bit better... My name is Cameron Smith. I'm...
We took some time to sit down and talk with Dr Sales so you could get to know him a bit better... My name is Kurt Sales. I’m...
Unraveling the Untapped Potential of Immuno-Oncology Technology Both the pace and varied methods by which medical clinicians ut...
A Quick Look at Agilex Biolabs' Expertise and Capabilities In the intricate landscape of drug discovery and development, the as...
Agilex Biolabs has extensive knowledge on small molecule development and pharmacokinetic services. Today, pharmacokinetics (PK)...
Agilex Biolabs integrates critical reagents services into comprehensive lifecycle management. The relationship between producin...
Agilex is pleased to introduce Mallory Jolly as our new Senior Business Development Director to the East Coast of the United State...
Agilex Demystifies the Rapidly Evolving Landscape of Drug Development Post-Covid, the field of bioanalysis has undergone signif...
As Agilex Biolabs continues its global expansion and corporate evolution as part of the Healius network, Stephen McIntyre has been selected to take the position of Chief Executive Officer.
